Sinus node dysfunction and atrial fibrillation-Relationships, clinical phenotypes, new mechanisms, and treatment approaches

被引:10
作者
Duan, Suhang [1 ]
Du, Jianlin [1 ]
机构
[1] Chongqing Med Univ, Affiliated Hosp 2, Dept Cardiol, 74 Lin Jiang Rd, Chongqing 400010, Peoples R China
基金
中国国家自然科学基金;
关键词
Sinus node dysfunction; Atrial fibrillation; HCN4; Ganglionated plexus; Neuromodulation; TACHYCARDIA-BRADYCARDIA SYNDROME; PULMONARY VEIN ISOLATION; VAGUS NERVE-STIMULATION; CANINE HEART-FAILURE; SINOATRIAL NODE; CARDIAC AMYLOIDOSIS; GROWTH-FACTOR; CATHETER ABLATION; DOWN-REGULATION; UP-REGULATION;
D O I
10.1016/j.arr.2023.101890
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Although the anatomical basis of the pathogenesis of sinus node dysfunction (SND) and atrial fibrillation (AF) is located primarily in the left and right atria, increasing evidence suggests a strong correlation between SND and AF, in terms of both clinical presentation and formation mechanisms. However, the exact mechanisms underlying this association are unclear. The relationship between SND and AF may not be causal, but is likely to involve common factors and mechanisms, including ion channel remodeling, gap junction abnormalities, structural remodeling, genetic mutations, neuromodulation abnormalities, the effects of adenosine on cardiomyocytes, oxidative stress, and viral infections. Ion channel remodeling manifests primarily as alterations in the "funny" current (I-f) and Ca2+ clock associated with cardiomyocyte autoregulation, and gap junction abnormalities are manifested primarily as decreased expression of connexins (Cxs) mediating electrical impulse propagation in cardiomyocytes. Structural remodeling refers primarily to fibrosis and cardiac amyloidosis (CA). Some genetic mutations can also cause arrhythmias, such as SCN5A, HCN4, EMD, and PITX2. The intrinsic cardiac autonomic nervous system (ICANS), a regulator of the heart's physiological functions, triggers arrhythmias.In addition, we discuss arrhythmias caused by viral infections, notably Coronavirus Disease 2019 (COVID-19). Similarly to upstream treatments for atrial cardiomyopathy such as alleviating CA, ganglionated plexus (GP) ablation acts on the common mechanisms between SND and AF, thus achieving a dual therapeutic effect.
引用
收藏
页数:13
相关论文
共 205 条
[11]   Control of cardiac rate by "Funny" channels in health and disease [J].
Barbuti, Andrea ;
DiFrancesco, Dario .
CONTROL AND REGULATION OF TRANSPORT PHENOMENA IN THE CARDIAC SYSTEM, 2008, 1123 :213-223
[12]   Refining Atrial Fibrillation Stroke Risk Estimates-A Call for Thoughtful Implementation Planning [J].
Barnes, Geoffrey D. .
JAMA NETWORK OPEN, 2022, 5 (08) :E2229340
[13]  
Basu-Ray I., 2021, Cardiac manifestations of coronavirus (COVID-19)
[14]   Pulmonary intravascular coagulation in COVID-19: possible pathogenesis and recommendations on anticoagulant/thrombolytic therapy [J].
Belen-Apak, F. Burcu ;
Sarialioglu, F. .
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2020, 50 (02) :278-280
[15]   Structural Cardiac Remodeling in Atrial Fibrillation [J].
Beyer, Christoph ;
Tokarska, Lyudmyla ;
Stuhlinger, Markus ;
Feuchtner, Gudrun ;
Hintringer, Florian ;
Honold, Sarah ;
Fiedler, Lukas ;
Schonbauer, Marie-Sophie ;
Schonbauer, Robert ;
Plank, Fabian .
JACC-CARDIOVASCULAR IMAGING, 2021, 14 (11) :2199-2208
[16]   Ischemic Stroke in Patients With Sinus Node Disease, Atrial Fibrillation, and Other Cardiac Conditions [J].
Bodin, Alexandre ;
Bisson, Arnaud ;
Gaborit, Christophe ;
Herbert, Julien ;
Clementy, Nicolas ;
Babuty, Dominique ;
Lip, Gregory Y. H. ;
Fauchier, Laurent .
STROKE, 2020, 51 (06) :1674-1681
[17]   Sinoatrial nodal cell ryanodine receptor and Na+-Ca2+ exchanger -: Molecular partners in pacemaker regulation [J].
Bogdanov, KY ;
Vinogradova, TM ;
Lakatta, EG .
CIRCULATION RESEARCH, 2001, 88 (12) :1254-1258
[18]   Interaction between direct sympathetic and vagus nerve stimulation on heart rate in the isolated rabbit heart [J].
Brack, KE ;
Coote, JH ;
Ng, GA .
EXPERIMENTAL PHYSIOLOGY, 2004, 89 (01) :128-139
[19]   Phasic left atrial strain analysis to discriminate cardiac amyloidosis in patients with unclear thick heart pathology [J].
Brand, Anna ;
Frumkin, David ;
Huebscher, Anne ;
Dreger, Henryk ;
Stangl, Karl ;
Baldenhofer, Gerd ;
Knebel, Fabian .
EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING, 2021, 22 (06) :680-687
[20]   Atrial Fibrillation, Thromboembolic Risk, and Anticoagulation in Cardiac Amyloidosis: A Review [J].
Bukhari, Syed ;
Khan, Syed Zamrak ;
Bashir, Zubair .
JOURNAL OF CARDIAC FAILURE, 2023, 29 (01) :76-86